Related Experiment Video
Updated: Jun 23, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Origin licensing and p53 status regulate Cdk2 activity during G(1)
Kathleen R Nevis1, Marila Cordeiro-Stone, Jeanette Gowen Cook
1Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Abstract:
Origins of DNA replication are licensed through the assembly of a chromatin-bound prereplication complex. Multiple regulatory mechanisms block new prereplication complex assembly after the G(1)/S transition to prevent rereplication. The strict inhibition of licensing after the G(1)/S transition means that all origins used in S phase must have been licensed in the preceding G(1). Nevertheless mechanisms that coordinate S phase entry with the completion of origin licensing are still poorly understood. We demonstrate that depletion of either of two essential licensing factors, Cdc6 or Cdt1, in normal human fibroblasts induces a G(1) arrest accompanied by inhibition of cyclin E/Cdk2 activity and hypophosphorylation of Rb. The Cdk2 inhibition is attributed to a reduction in the essential activating phosphorylation of T160 and an associated delay in Cdk2 nuclear accumulation. In contrast, licensing inhibition in the HeLa or U2OS cancer cell lines failed to regulate Cdk2 or Rb phosphorylation, and these cells died by apoptosis. Co-depletion of Cdc6 and p53 in normal cells restored Cdk2 activation and Rb phosphorylation, permitting them to enter S phase with a reduced rate of replication and also to accumulate markers of DNA damage. These results demonstrate dependence on origin licensing for multiple events required for G(1) progression, and suggest a mechanism to prevent premature S phase entry that functions in normal cells but not in p53-deficient cells.
Insights
Origin licensing, crucial for DNA replication, prevents rereplication. Inhibiting licensing factors Cdc6 or Cdt1 in normal cells causes G1 arrest, while cancer cells undergo apoptosis, revealing cell-type specific responses.
Area of Science:
- Cell Cycle Regulation
- DNA Replication Licensing
- Molecular Biology
Background:
- DNA replication origins are licensed by prereplication complexes during G1 phase.
- Regulatory mechanisms prevent new licensing after the G1/S transition to avoid rereplication.
- Coordination between S phase entry and origin licensing completion is not fully understood.
Purpose of the Study:
- To investigate the role of origin licensing factors Cdc6 and Cdt1 in cell cycle progression.
- To elucidate the mechanisms coordinating S phase entry with origin licensing.
- To compare the effects of licensing inhibition in normal versus cancer cells.
Main Methods:
- Depletion of essential licensing factors Cdc6 or Cdt1 in normal human fibroblasts.
- Analysis of cell cycle arrest, cyclin E/Cdk2 activity, and Rb phosphorylation.
- Comparison of licensing inhibition effects in HeLa and U2OS cancer cell lines.
- Co-depletion of Cdc6 and p53 in normal cells to assess p53's role.
Main Results:
- Depletion of Cdc6 or Cdt1 in normal fibroblasts induced G1 arrest, inhibited cyclin E/Cdk2 activity, and caused Rb hypophosphorylation.
- Inhibition of licensing in cancer cells led to apoptosis, without affecting Cdk2 or Rb phosphorylation.
- Co-depletion of Cdc6 and p53 in normal cells restored Cdk2 activation and Rb phosphorylation, allowing S phase entry with DNA damage.
Conclusions:
- Origin licensing is essential for multiple G1 progression events in normal cells.
- A mechanism preventing premature S phase entry relies on origin licensing and p53.
- This mechanism functions in normal cells but is impaired in p53-deficient cancer cells.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Positive Regulator Molecules

